Skip to main content

Table 4 Results from statistical modelling (Random effects Model)

From: Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

 

EQ-5D-5L

EQ-5D-3L

 

Estimate

SE

P-value

Estimate

SE

P-value

Intercept

0.2255

0.09157

0.0142

0.08046

0.08507

0.3450

Physical Functioning

0.006418*

0.000676

<.0001

0.006137*

0.000620

<.0001

Role Functioning

-0.00032

0.000591

0.5935

0.001392*

0.000509

0.0066

Emotional Functioning

0.001871*

0.000554

0.0008

0.001949*

0.000481

<.0001

Cognitive Functioning

-0.00057

0.000491

0.2436

-0.00073

0.000448

0.1024

Social Functioning

0.000387

0.000530

0.4664

0.000516

0.000462

0.2652

Global health status / QoL

-0.00109*

0.000409

0.0082

-0.00043

0.000401

0.2853

Fatigue

0.000324

0.000696

0.6420

0.000993

0.000647

0.1261

Nausea / Vomiting

-0.00041

0.000600

0.4990

0.000276

0.000524

0.5993

Pain

-0.00311*

0.000495

<.0001

-0.00215*

0.000427

<.0001

Dyspnoea

0.000368

0.000464

0.4287

-0.00011

0.000421

0.7915

Insomnia

-0.00017

0.000338

0.6218

-0.00004

0.000313

0.9053

Appetite loss

-0.00030

0.000328

0.3673

0.000341

0.000295

0.2488

Constipation

-0.00013

0.000359

0.7139

0.000524

0.000306

0.0877

Diarhoea

0.001155*

0.000438

0.0087

0.000499

0.000425

0.2409

Financial Problems

0.000345

0.000334

0.3019

-0.00004

0.000297

0.9039

  1. *Statistically significant at the two-sided 5 % level